Genus (LON:GNS) Earns Buy Rating from Shore Capital

Genus (LON:GNS)‘s stock had its “buy” rating reaffirmed by Shore Capital in a report issued on Wednesday,Digital Look reports.

Genus Trading Up 1.1 %

LON:GNS opened at GBX 1,660 ($21.21) on Wednesday. The firm has a market capitalization of £1.09 billion, a P/E ratio of 13,833.33, a P/E/G ratio of 2.87 and a beta of 0.37. Genus has a 52 week low of GBX 1,478 ($18.88) and a 52 week high of GBX 2,378 ($30.38). The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.54. The company has a fifty day moving average of GBX 1,907.74 and a 200 day moving average of GBX 1,822.87.

Insider Buying and Selling

In other Genus news, insider Jorgen Kokke sold 2,186 shares of the company’s stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($24.99), for a total value of £42,758.16 ($54,629.05). 0.75% of the stock is currently owned by corporate insiders.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.